[8-K] Boundless Bio, Inc. Reports Material Event
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Boundless Bio, Inc. held its annual stockholder meeting on June 15, 2026, where two proposals were approved. Stockholders elected James Christensen, Ph.D. and Jennifer Lew as Class II directors to serve until the 2029 annual meeting and until their successors are elected and qualified.
Christensen received 9,287,096 votes for and 512,585 votes withheld, while Lew received 9,271,084 votes for and 528,597 votes withheld; each had 5,757,105 broker non-votes. Stockholders also ratified KPMG LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 15,376,973 votes for, 127,747 against and 52,066 abstentions.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Annual meeting date: June 15, 2026
Votes for James Christensen: 9,287,096 votes
Votes for Jennifer Lew: 9,271,084 votes
+5 more
8 metrics
Annual meeting date
June 15, 2026
Date of Boundless Bio’s annual stockholder meeting
Votes for James Christensen
9,287,096 votes
Director election at 2026 annual meeting
Votes for Jennifer Lew
9,271,084 votes
Director election at 2026 annual meeting
Broker non-votes on director elections
5,757,105 votes
Same broker non-vote count for each nominee
Votes for KPMG ratification
15,376,973 votes
Ratification of independent auditor for 2026 fiscal year
Votes against KPMG ratification
127,747 votes
Opposing votes on auditor ratification proposal
Abstentions on KPMG ratification
52,066 votes
Abstaining votes on auditor ratification proposal
Director term end
2029 annual meeting
End of Class II directors’ term of office
Key Terms
broker non-votes, independent registered public accounting firm, Class II director
3 terms
broker non-votes financial
"Votes For | Votes Against | Abstentions | Broker Non-Votes"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
Class II director financial
"Each of the director nominees was elected as a Class II director to hold office"
A class II director is a member of a company’s board who belongs to one of several staggered groups of directors, each group standing for election in different years. For investors, this matters because staggered terms slow wholesale board turnover—like rotating members of a neighborhood committee—making sudden changes in control or strategy harder and affecting how quickly shareholders can influence corporate direction.
FAQ
What did Boundless Bio (BOLD) stockholders vote on at the 2026 annual meeting?
Stockholders voted on electing two Class II directors and ratifying KPMG LLP as auditor. Both proposals were approved, confirming the board slate and the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Who was elected to Boundless Bio (BOLD)’s board at the June 15, 2026 meeting?
James Christensen, Ph.D., and Jennifer Lew were elected as Class II directors. They will serve until Boundless Bio’s 2029 annual meeting of stockholders and continue until their respective successors are duly elected and qualified.
How many votes did Boundless Bio (BOLD) director nominees receive in 2026?
James Christensen, Ph.D., received 9,287,096 votes for and 512,585 withheld, while Jennifer Lew received 9,271,084 votes for and 528,597 withheld. Each nominee also had 5,757,105 broker non-votes recorded in the final tabulation.
Which auditing firm did Boundless Bio (BOLD) stockholders ratify for 2026?
Stockholders ratified KPMG LLP as Boundless Bio’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The ratification received 15,376,973 votes for, 127,747 against, and 52,066 abstentions, with no broker non-votes reported.
When was Boundless Bio (BOLD)’s 2026 annual stockholder meeting held?
The annual meeting of stockholders was held on June 15, 2026. At this meeting, investors voted on electing two Class II directors and on ratifying KPMG LLP as the company’s independent registered public accounting firm for the 2026 fiscal year.